Treatment of impaired cognition with nootropic drugs: nicergoline versus the state of the art.
Fariello
R G
RG
Department of Neurology, T. Jefferson University, Philadelphia PA 19107, USA.
D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000523:psychology; D002986:Clinical Trials as Topic; D003072:Cognition Disorders / Q000188:drug therapy* / Q000523:psychology; D003704:Dementia / Q000188:drug therapy* / Q000523:psychology; D006801:Humans; D008609:Mental Status Schedule; D009483:Neuropsychological Tests; D009530:Nicergoline / Q000009:adverse effects / Q000627:therapeutic use*; D018697:Nootropic Agents / Q000009:adverse effects / Q000627:therapeutic use*
D018697:Nootropic Agents; D009530:Nicergoline